Page last updated: 2024-09-03

celastrol and Guillain-Barre Syndrome

celastrol has been researched along with Guillain-Barre Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Fan, W; Shao, H; Tang, Y	1

Other Studies

1 other study(ies) available for celastrol and Guillain-Barre Syndrome

Article	Year
Celastrol attenuates Guillain-Barré syndrome by inhibiting TLR4/NF-κB/STAT3 pathway-mediated Th1/Th17 cell differentiation. General physiology and biophysics, 2023, Volume: 42, Issue:1 Topics: Animals; Cell Differentiation; Guillain-Barre Syndrome; Interleukin-17; Interleukin-18; Interleukin-23; NF-kappa B; Nuclear Receptor Subfamily 1, Group F, Member 3; Rats; Th17 Cells; Toll-Like Receptor 4	2023

Article

Year

Celastrol attenuates Guillain-Barré syndrome by inhibiting TLR4/NF-κB/STAT3 pathway-mediated Th1/Th17 cell differentiation.

General physiology and biophysics, 2023, Volume: 42, Issue:1

Topics: Animals; Cell Differentiation; Guillain-Barre Syndrome; Interleukin-17; Interleukin-18; Interleukin-23; NF-kappa B; Nuclear Receptor Subfamily 1, Group F, Member 3; Rats; Th17 Cells; Toll-Like Receptor 4

2023